JOGENDRA SINGH: Open Payments
NPI 1174998843 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,385 in 206 payments from 21 companies in 2025. Trend: 2023 $2,679 · 2024 $3,189 · 2025 $4,385
Food & beverage: $4,385
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $663 |
| E.R. Squibb & Sons, L.L.C. | 30 | $565 |
| ABBVIE INC. | 22 | $539 |
| Otsuka America Pharmaceutical, Inc. | 21 | $500 |
| Alkermes, Inc. | 15 | $367 |
| Janssen Pharmaceuticals, Inc | 15 | $331 |
| Neurocrine BioSciences, Inc. | 14 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $196 |
| Lundbeck LLC | 15 | $188 |
| Vanda Pharmaceuticals Inc. | 10 | $182 |
Products named: VRAYLAR, AUSTEDO XR, REXULTI, COBENFY, INGREZZA, INVEGA SUSTENNA, ARISTADA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
